AMCP announced today that Phil Bongiorno has joined the organization as vice president, policy & government relations. In this role, he will oversee AMCP’s many advocacy efforts to advance managed care pharmacy principles and practices through health care legislation and regulation at both the federal and state levels.

AMCP last week gathered a group of diverse health care stakeholders to discuss the challenges and opportunities of ensuring patient access to a category of emerging therapies known as “digital therapeutics,” which have the potential to treat a wide range of diseases and medical conditions.

Press Release: AMCP comments in joint statement on the Administration’s latest initiative to modernize substance use disorder (SUD) treatment privacy law and enhance coordinated care and safety.

Press Release: The Trump Administration today pulled its proposed rule to eliminate safe harbor protections for rebates paid by pharmaceutical manufacturers to PBMs and health plans in Medicare and Medicaid programs.

Press Release: Focusing on what’s best for the patient, leveraging technology to perform real-time benefit checks, and developing trust and transparency among stakeholders are some of the suggestions to emerge from AMCP’s recent Partnership Forum on “Optimizing Prior Authorization for Appropriate Medication Selection.”

Press Release: The Academy of Managed Care Pharmacy (AMCP) has developed nine concepts around the effective use of prior authorization that managed care organizations can follow to ensure that PA processes are timely, transparent, collaborative and supportive of patient-centered care.

Press Release: From News&Views April 2019: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies.